Celsius Holdings has delivered a robust comeback, with shares climbing over 65% in the last 12 months while still trading approximately 50% below their all-time high. The company’s current market capitalization stands near $12.4 billion, supported by a forward price-to-earnings ratio of roughly 32.0. These valuation metrics suggest that, despite elevated multiples typical of mid-cap growth names, the stock still offers room for upside if revenue and margins continue to expand as expected.

In a bid to deepen its footprint in the health and wellness sector, Celsius closed its acquisition of Alani Nu, a fast-growing supplement brand, last year. This deal not only broadens Celsius’ distribution into protein supplements and functional nutrition, but also leverages Alani Nu’s existing direct-to-consumer channels and retail partnerships. Management projects that synergies from cross-selling opportunities and combined marketing efforts could drive a 5–7% lift in consolidated gross margins by the end of fiscal 2026.

Looking ahead, Celsius aims to sustain mid-teens top-line growth by capitalizing on rising consumer demand for healthier energy beverages and supplements. Initiatives include new product launches in Europe and Asia, an expanded loyalty program in North America, and investments in production capacity to support annual volume growth of 20%. Analysts forecast adjusted EBITDA to advance by more than 25% next year, reflecting both incremental operating leverage and ongoing cost-efficiency measures.